How research peptides are made: solid-phase synthesis, Fmoc and Boc protection strategies, coupling chemistry, cleavage, preparative HPLC purification, lyophilization, and the impurities each step can leave behind.
Nearly every research peptide in use today was assembled one amino acid at a time on a solid support, cut free with strong acid, purified by chromatography, and freeze-dried. Each of those steps leaves its own signature in the finished material, including which impurities are likely, what counter-ion the peptide carries, and why net peptide content differs from the weight of the powder. Knowing how a peptide is made makes it much easier to read an analytical report critically and to anticipate problems in an experiment.
Early peptide chemistry was done entirely in solution, where every intermediate had to be isolated and purified before the next residue could be added. That made even short peptides slow to produce. In 1963 Bruce Merrifield described a different approach: anchor the first amino acid to an insoluble polymer bead and build the chain on it, so that excess reagents and by-products can simply be washed away after each step [1]. The method, solid-phase peptide synthesis (SPPS), earned Merrifield the 1984 Nobel Prize in Chemistry and remains the basis of peptide manufacturing.
In 1972 Louis Carpino and Grace Han introduced the 9-fluorenylmethoxycarbonyl (Fmoc) amino-protecting group, which can be removed under mild basic conditions [2]. A review of the field describes Fmoc SPPS as the method of choice today, with very high-quality Fmoc amino acid building blocks available at low cost because therapeutic peptides are now produced at multi-ton scale by the same chemistry [3].
SPPS builds the chain from the C-terminus to the N-terminus, the opposite of the direction ribosomes use. The choice of resin and linker determines what the C-terminus will be once the peptide is released; some linkers give a free carboxylic acid and others give a C-terminal amide. After the first residue is attached, the chain grows through repeated rounds of the same steps:
The arithmetic of repetition is what makes long peptides hard. As an illustration, if every coupling were 99% complete, a 30-residue chain would contain only about 74% full-length product before any other losses, because 0.99 multiplied by itself 30 times is roughly 0.74. The rest would be a family of closely related shorter sequences. Length is not the only factor, though. A review of Fmoc SPPS notes that the often-quoted figure of around 50 residues as a routine limit is of little practical meaning, since many much shorter sequences are extremely difficult to make [3].
Amino acids carry reactive groups besides the ones meant to form the peptide bond, so every side chain that could interfere must be masked. SPPS relies on two tiers of protection: a temporary group on the alpha-amino end, removed at every round, and permanent groups on the side chains, removed only at the end. The two tiers must come off under different conditions, a property chemists call orthogonality.
In the Fmoc strategy, the alpha-amino group is protected with Fmoc and removed at each round with a base, usually piperidine, while side chains carry acid-labile tert-butyl-type groups that come off in the final trifluoroacetic acid (TFA) cleavage. The review notes two reasons the method spread quickly: it avoided the anhydrous hydrogen fluoride required by the older chemistry, and removing Fmoc releases a fluorene by-product with strong UV absorbance, which lets instruments monitor each deprotection step [3].
The original Merrifield chemistry used the tert-butyloxycarbonyl (Boc) group, removed at each round with TFA, with benzyl-type side-chain protection and a final cleavage in anhydrous hydrogen fluoride. Hydrogen fluoride is highly hazardous and needs dedicated equipment, which is the main reason Boc chemistry is now used mostly for specialized cases, such as certain aggregation-prone sequences and peptide thioesters.
A carboxylic acid and an amine do not form an amide bond efficiently on their own, so the incoming amino acid's carboxyl group is first activated. The available coupling reagents are numerous enough that one comprehensive review titled itself "more than a letter soup" [4]. The main families are:
Coupling reagents deserve respect in the lab. A 2020 case report from a university peptide group described anaphylaxis following repeated exposure to HATU, HBTU, and HCTU, and warned that peptide coupling agents are immune sensitizers [5]. Labs that synthesize peptides handle these powders with the same care given to other sensitizing chemicals.
Some sequences fold into beta-sheet-like structures while still attached to the resin, and the chains aggregate so that reagents cannot reach the reactive end. According to the Fmoc SPPS review, much of the progress in making longer peptides came from pseudoproline building blocks and backbone amide protection, both of which disrupt the hydrogen bonding that drives this aggregation [3].
When the chain is complete, the resin is exposed to a concentrated TFA mixture that releases the peptide and strips the side-chain protecting groups in one step. Those protecting groups leave as reactive carbocations that can attach to electron-rich residues such as tryptophan, methionine, cysteine, and tyrosine, so the cleavage mixture includes scavengers, typically water and a silane, with thiols added for some sequences. The crude peptide is then usually precipitated in cold ether, collected, and dried.
Crude peptide is a mixture of the target sequence and its synthetic relatives. Reversed-phase HPLC is the workhorse for separating them: the mixture is loaded onto a hydrophobic stationary phase, commonly C18-bonded silica, and eluted with a gradient of increasing acetonitrile in water, with TFA added as an ion-pairing agent to sharpen peaks. Ion-exchange and size-exclusion chromatography are used as complementary modes, for example to separate by charge or to assess oligomerization [6]. Fractions are analyzed, those meeting the purity target are pooled, and the rest are discarded or reprocessed. Impurities that differ from the target by a single residue can elute very close to it, which is why achieving higher purity often costs disproportionately more yield.
Pooled fractions are freeze-dried. The solution is frozen, the ice is removed by sublimation under vacuum, and a secondary drying phase removes much of the remaining bound water. The result is the familiar white powder or cake, which is far more stable than the peptide in solution.
Because TFA is present during cleavage and purification, peptides purified by HPLC are often isolated as trifluoroacetate salts. This matters in biological work. A 1999 cell study found that TFA at concentrations of 10^-8 to 10^-7 M reduced cell numbers in fetal rat osteoblast cultures, and that the TFA salts of amylin and calcitonin produced less cell proliferation than their hydrochloride salts, enough to hide a real proliferative effect or suggest a false antiproliferative one. The authors recommended converting peptides to a hydrochloride or other biologically equivalent salt before testing biological effects [7]. Counter-ions and residual water also add weight, which is why the net peptide content of a vial is lower than the mass of powder in it.
A structured review of impurities in peptide medicines groups them by origin [8]. Each has a recognizable cause, and many can be spotted with the combination of HPLC and mass spectrometry that appears on a certificate of analysis.
Aspartimide formation deserves particular mention. The repeated exposure to base in Fmoc chemistry can cyclize aspartic acid residues, and the resulting intermediate can open into as many as nine different by-products, some of which co-elute with the target peptide and are very difficult to resolve by HPLC [3]. Mass spectrometry does not always help either, since some of these by-products have the same mass as the intended peptide.
Note: Northbridge Research Labs supplies synthetic peptides for laboratory research use only. They are not for human or veterinary use. This article describes manufacturing chemistry for educational purposes.
What peptides are, how the peptide bond and side chains shape their behavior, how research peptides are synthesized and purified, and what that chemistry means for everyday lab work.
A working guide to the 20 standard amino acids: their structure, charge and hydrophobicity, how individual residues shape peptide conformation and stability, and what that means for solubility and handling in the lab.
Research Use Only: The information in this article is for educational and research purposes only. All products mentioned are intended for laboratory research use only and are not approved for human or veterinary use.